BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  C2C Services & Suppliers™
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile

 

Copernicus Therapeutics, Inc. 

11000 Cedar Avenue, Suite 120

Cleveland  Ohio  44106-3052  U.S.A.
Phone: 216-231-0227 Fax: 216-231-9477


SEARCH JOBS

View Clinical Trials from BioPharm Insight



Industry
Biotechnology






 Company News
Copernicus Therapeutics, Inc. to Further Development of Non-Viral Gene Therapy for Parkinson’s Disease 1/12/2009 8:43:20 AM
Case Western Reserve University with Copernicus Therapeutics, Inc. and Polgenix Receive $3.9 Million from the Ohio Biomedical Research Commercialization Program (BRCP) 7/1/2008 1:17:31 PM
Copernicus Therapeutics, Inc. Receives Milestone Payment from Cystic Fibrosis Foundation Therapeutics, Inc. to Further Development of its Non-Viral Gene Therapy for Cystic Fibrosis 12/11/2007 11:45:07 AM
Copernicus Therapeutics, Inc.' Nanoparticle Technology Applied to siRNA 6/5/2007 12:33:16 PM
Copernicus Therapeutics, Inc.: Vision Deficit in Retinitis Pigmentosa Mice Corrected with DNA Nanoparticles 6/4/2007 12:15:32 PM
Copernicus Therapeutics, Inc. To Receive Increased Support From Cystic Fibrosis Foundation Therapeutics, Inc. To Further Development Of Its Non-Viral Gene Therapy For Cystic Fibrosis 2/15/2007 11:47:54 AM
Copernicus Therapeutics, Inc. Release: Manuscript Demonstrates Remarkable DNA Delivery And Expression In The Mouse Retina 1/9/2007 1:04:37 PM
Copernicus Therapeutics, Inc. Demonstrates Ability Of Its Non-Viral Delivery System To Efficiently Transfer Large Sizes Of Nucleic Acid Into Lung Cells 7/7/2006 11:54:03 AM
Copernicus Therapeutics, Inc. To Receive Continued Support From Cystic Fibrosis Foundation Therapeutics, Inc. To Further Develop Non-Viral Gene Therapy For Cystic Fibrosis 2/14/2006 12:51:40 PM
Copernicus Therapeutics, Inc. Receives $1 Million From Cystic Fibrosis Foundation Therapeutics To Advance Development Of A Non-Viral Gene Therapy For Cystic Fibrosis10/19/2005 5:12:27 PM
12